Reduction in the virulence of Mycobacterium tuberculosis and protection against tuberculosis by means of phoP gene inactivation
专利汇可以提供Reduction in the virulence of Mycobacterium tuberculosis and protection against tuberculosis by means of phoP gene inactivation专利检索，专利查询，专利分析的服务。并且The construction of a mutant in the phoP gene by means of homologous recombination from a clinically isolated Mycobacterium tuberculosis reduces the virulence thereof in mouse bone marrow macrophage. Moreover, the phoP mutant reduces the virulence thereof in the experimental mouse model. Said phoP mutant can persist without being eliminated both in the macrophage and in the mouse. Mice inoculated with the phoP mutant are protected against M. tuberculosis infection. The use of mutants of mycobacteria in which the phoP gene or the genes regulated by phoP have been inactivated are candidates for vaccines against human and animal tuberculosis as well as possible recombinant vaccines against other pathogens.，下面是Reduction in the virulence of Mycobacterium tuberculosis and protection against tuberculosis by means of phoP gene inactivation专利的具体信息内容。
The invention claimed is:
This application is a 371(c) National Stage of PCT/ES02/00381 filed Jul. 20, 2002, which claims priority to Spanish patent application P 200101824 filed Jul. 31, 2001, the entire disclosures of which are incorporated herein incorporated by reference.
This invention pertains to the field of microbiology.
Recent developments of genetic tools for manipulating the tuberculosis bacillus make possible the construction of mutants in specific genes.
In other intracellular pathogen microorganisms such as Salmonella it has been described that the phoP gene is involved in the virulence. Inactivation of this gene has permitted the construction of attenuated mutants, which have been studied as vaccines against Salmonellosis in humans.
Our preliminary results (University of Zaragoza) in strains of the M. tuberculosis complex isolated from humans have indicated that possibly the most virulent strains have an alteration of the gene annotated in the M. tuberculosis genome as phoP.
The gene was inactivated in clinical isolation for the purpose of studying the involvement of phoP in M. tuberculosis virulence and its multiplication ability and persistence in macrophage and mouse.
Vectors were constructed where the phoP gene of M tuberculosis was inactivated by the introduction of a gene resistant to kanamicin. The vectors were transformed into a clinical isolate of M tuberculosis and a strain with the inactivated phoP gene was obtained.
Work relating to these constructions was recorded in the 1998-1999 workbooks of the Genetics Mico-bacteria Group laboratories of the University of Zaragoza and the Unité de Génétique Mycoctérienne of the Pasteur Institute of Paris.
The phoP mutant of M. tuberculosis has been deposited in the culture collection of the Pasteur Institute of Paris (I-2622), 28, rue du Dr. Roux, 75724 Paris Cedex 15, France, on Nov. 27, 2000.
When M. tuberculosis was studied and compared with the mutant M. tuberculosis phoP strain for 7 days in mouse bone marrow macrophages, it was observed that the mutant was not able to replicate in mammal macrophage. By continuing with the culture of the mutant for 14 days, it was observed that it was able to persist.
After infecting a mouse with the mutant strain, it was observed that there is no multiplication of the bacillus at 3 weeks or at 6 weeks, but the number of bacteria in the spleen, the liver, and the lungs is not reduced as compared with the initial inoculation.
The results of experiments with the M. tuberculosis phoP in macrophage and mouse are contained in the workbooks of the Genetics Mico-bacteria Group laboratories of the University of Zaragoza and the Unité de Génétique Mycoctérienne of the Pasteur Institute of Paris for the year 2000.
The mouse protection studies discussed below under the Description of Figures should be considered with these results. The M. tuberculosis phoP mutant was inoculated subcutaneously. Eight weeks later, the mice were intravenously infected with M. tuberculosis H37Rv. Bacterial count 4 weeks after infection clearly shows that the phoP mutant protects against the multiplication of M. tuberculosis with an effectiveness comparable to the BCG vaccine control. The results of the experiments are contained in the workbooks of the Unité de Génétique Mycoctérienne of the Pasteur Institute of Paris for the years 2001-2002.
Balb/c mice were inoculated subcutaneously with 107 colony forming units (CFUs) either of BCG control vaccine against tuberculosis or of candidate for vaccine of the M. tuberculosis phoP mutant.
Eight weeks later, the mice were infected intravenously with M. tuberculosis H37Rv (105 CFUs). Four weeks after infection, the animals were sacrificed and CFUs were counted in the spleen (
| 标题 | 发布/更新时间 | 阅读量 |
|---|---|---|
| 一种四氢嘧啶高产谷氨酸棒杆菌及其应用 | 2020-05-24 | 1 |
| 一种用蜜源菌制作天竺葵护肤酵素的方法 | 2020-11-16 | 0 |
| 农业废弃物饲料资源化利用的一种方法 | 2022-07-05 | 1 |
| 诊前病史采集方法及执行该方法的机器可读存储介质 | 2020-08-03 | 0 |
| 一种毛叶山桐子的组织培养育苗方法 | 2020-12-16 | 1 |
| 生物催化不对称还原制备(R)-邻氯扁桃酸甲酯的方法 | 2022-05-26 | 1 |
| 一种污泥发酵耦合生物脱氮系统 | 2020-05-29 | 2 |
| 一种红景天药物产品活性物的制备方法 | 2020-06-29 | 0 |
| 一种病死猪蝇蛆生态处理方法 | 2020-12-21 | 0 |
| 甘蔗脱毒健康种苗无菌外植体的制备方法 | 2020-10-31 | 0 |
高效检索全球专利专利汇是专利免费检索,专利查询,专利分析-国家发明专利查询检索分析平台，是提供专利分析，专利查询，专利检索等数据服务功能的知识产权数据服务商。
我们的产品包含105个国家的1.26亿组数据，免费查、免费专利分析。
专利汇分析报告产品可以对行业情报数据进行梳理分析，涉及维度包括行业专利基本状况分析、地域分析、技术分析、发明人分析、申请人分析、专利权人分析、失效分析、核心专利分析、法律分析、研发重点分析、企业专利处境分析、技术处境分析、专利寿命分析、企业定位分析、引证分析等超过60个分析角度，系统通过AI智能系统对图表进行解读，只需1分钟，一键生成行业专利分析报告。
